Notice: Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning a Chimeric Ebola and 
Marburg Virus Glycoproteins Virus Like Particle Vaccine To Protect 
Against Diverse Ebola and Marburg Viruses

Federal Register: April 21, 2010 (Volume 75, Number 76)           
                  Page 20828

AGENCY: Department of the Army, DoD.

ACTION: Notice.

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent Application Serial No. 61/338,967, 
entitled ``A Chimeric Ebola and Marburg Virus Glycoproteins Virus Like 
Particle Vaccine To Protect Against Diverse Ebola and Marburg 
Viruses.'' The United States Government, as represented by the 
Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to a chimeric Ebola 
and Marburg virus glycoproteins virus like particle vaccine and its use 
to protect against highly fatal diverse Ebola and Marburg viruses, in 
which no vaccine or proven countermeasure exists.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-9150 Filed 4-20-10; 8:45 am]
BILLING CODE 3710-08-P